The prevalence of type 2 diabetes is growing at an alarming rate with past forecasts being exceeded years before predicted. In 2017, over 420 million people were living with diabetes and this number is expected to continue rising with the increasing levels of obesity seen in populations around the world.
However, effective treatment alternatives are available to reduce the burden and manage the risk of complications of type 2 diabetes. Explore the type 2 diabetes section for expert insights into the future of diabetes, the need to address clinical inertia, and a Novartis-sponsored webinar.
Jump to each section by clicking below or continue scrolling down. The next page will load automatically.
Learn about the changing epidemiology of type 2 diabetes, the future of diabetes, the discovery of the first DPP-4 inhibitor and recent publications to mark 10 years of vildagliptin.
Which are the barriers to optimised diabetes care? Discover videos presentations from Dr David Strain, Dr Päivi Paldánius, Sir Michael Hirst and patient insights into the need to overcome combat clinical inertia in management of type 2 diabetes.
Watch a webinar series exploring the management of type 2 in female patients during the different stages of life, consisting of three presentations including 'The octogenarian female patient' and 'The dynamic and hormonal' and an interactive panel discussion.
Alternatively login via
Back to epgonline.org